Trial Profile
Effect of Combination tablets with telmisartan and amlodipine in hypertensive patients with metabolic syndrome not controlled by conventional therapy, randomized, open label, multicenter, parallel group study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Apr 2014
Price :
$35
*
At a glance
- Drugs Amlodipine/telmisartan (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms Cotalo
- 04 Oct 2012 Status changed from not yet recruiting to completed.
- 04 Oct 2012 Results presented at the 24th Annual Scientific Meeting of the American Society of Hypertension.
- 24 Mar 2011 New trial record